Cargando…

Caffeine intake interacts with Asian gene variants in Parkinson's disease: a study in 4488 subjects

BACKGROUND: Caffeine intake reduces risk of Parkinson's disease (PD), but the interaction with genes is unclear. The interaction of caffeine with genetic variants in those at high PD risk has healthcare importance. We investigate interactions of caffeine intake with risk variants found in Asian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ong, Yi-Lin, Deng, Xiao, Li, Hui-Hua, Narasimhalu, K., Chan, Ling-Ling, Prakash, Kumar M., Au, Wing-Lok, Ratnagopal, Pavanni, Tan, Louis C.S., Tan, Eng-King
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485627/ https://www.ncbi.nlm.nih.gov/pubmed/37691886 http://dx.doi.org/10.1016/j.lanwpc.2023.100877

Ejemplares similares

Differential effect of caffeine intake in subjects with genetic susceptibility to Parkinson’s Disease
por: Kumar, Prakash M., et al.
Publicado: (2015)

Case Control Polysomnographic Studies of Sleep Disorders in Parkinson's Disease
por: Yong, Ming-Hui, et al.
Publicado: (2011)

Association Analysis of COQ2 Variant in Dementia and Essential Tremor
por: Chao, Yin Xia, et al.
Publicado: (2015)

4488 Neural Network of the Cognitive Model of Reading
por: Posner, Joseph, et al.
Publicado: (2020)

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?
por: Wen, Ming-Ching, et al.
Publicado: (2017)

Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease
por: Shen, Nan, et al.
Publicado: (2023)

Attitude of Asian Parkinson Patients towards Clinical Research and Tissue Donation
por: Khan, Shazma, et al.
Publicado: (2020)

COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD
por: Yeo, Tianrong, et al.
Publicado: (2022)

LRRK2 A419V Is Not Associated with Parkinson's Disease in Different Chinese Populations
por: Wu, Yih Ru, et al.
Publicado: (2012)

Lrrk2 R1628P variant is a risk factor for essential tremor
por: Chao, Yin Xia, et al.
Publicado: (2015)

Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson's disease
por: Foo, Heidi, et al.
Publicado: (2016)

Case-control analysis of LRRK2 protective variants in Essential Tremor
por: Ng, Adeline S. L., et al.
Publicado: (2018)

SNCA Rep1 microsatellite length influences non-motor symptoms in early Parkinson’s disease
por: Yong, Alisa CW, et al.
Publicado: (2020)

Patient-Centric Care for Parkinson's Disease: From Hospital to the Community
por: Aye, Yin Minn, et al.
Publicado: (2020)

Progressive Supranuclear Gaze Palsy with Predominant Cerebellar Ataxia: A Case Series with Videos
por: Xu, Zheyu, et al.
Publicado: (2017)

Increased Intake of Both Caffeine and Non-Caffeine Coffee Components Is Associated with Reduced NAFLD Severity in Subjects with Type 2 Diabetes
por: Coelho, Margarida, et al.
Publicado: (2022)

Parkinson’s disease following COVID-19: causal link or chance occurrence?
por: Li, Wei-Shan, et al.
Publicado: (2020)

Biomarker characterization of clinical subtypes of Parkinson Disease
por: Deng, Xiao, et al.
Publicado: (2022)

Physical Activity Improves Anxiety and Apathy in Early Parkinson's Disease: A Longitudinal Follow-Up Study
por: Ng, Samuel Yong-Ern, et al.
Publicado: (2021)

Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease
por: Wen, Ming-Ching, et al.
Publicado: (2017)

The Use of Caffeine Citrate for Respiratory Stimulation in Acquired Central Hypoventilation Syndrome: A Case Series
por: Ling Tan, Pei, et al.
Publicado: (2023)

Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
por: Tan, Wen-Qi, et al.
Publicado: (2015)

Salivary caffeine in Parkinson’s disease
por: Leodori, Giorgio, et al.
Publicado: (2021)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Adenosine A(2A) Receptor Occupancy by Caffeine After Coffee Intake in Parkinson's Disease
por: Ishibashi, Kenji, et al.
Publicado: (2022)

Caffeine Intake Among Adolescents in Delhi
por: Gera, Mridul, et al.
Publicado: (2016)

Cardiovascular Safety of Anagrelide in Healthy Subjects: Effects of Caffeine and Food Intake on Pharmacokinetics and Adverse Reactions
por: Martínez-Sellés, Manuel, et al.
Publicado: (2012)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Immunotherapy trials in Parkinson’s disease: challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

2,2,6,6-Tetrakis(biphenyl-2-yl)-4,4,8,8-tetramethylcyclotetrasiloxane
por: Couzijn, Erik P. A., et al.
Publicado: (2009)

Plasma ubiquitin C-terminal hydrolase L1 levels reflect disease stage and motor severity in Parkinson’s disease
por: Ng, Adeline Su Lyn, et al.
Publicado: (2020)

Case-control study of hypertension and Parkinson’s disease
por: Ng, Yuen-Fann, et al.
Publicado: (2021)

Cell replacement for Parkinson’s disease: advances and challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical Trials
por: Jang, Se Eun, et al.
Publicado: (2020)

White matter microstructural characteristics in newly diagnosed Parkinson’s disease: An unbiased whole-brain study
por: Wen, Ming-Ching, et al.
Publicado: (2016)

Caffeine Intake, Plasma Caffeine Level, and Kidney Function: A Mendelian Randomization Study
por: Giontella, Alice, et al.
Publicado: (2023)

Rhabdomyolysis from Resistance Exercise and Caffeine Intake
por: SUNG, Dong Jun, et al.
Publicado: (2018)

Time to Recover From Daily Caffeine Intake
por: Lin, Yu-Shiuan, et al.
Publicado: (2022)

Caffeine Intake and Mental Health in College Students
por: Bertasi, Raphael A. O, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fvs8jcpq5ik9d7dfgogmve4odn